Captrust Financial Advisors purchased a new position in shares of Walgreens Boots Alliance Inc (NASDAQ:WBA) during the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm purchased 2,678 shares of the pharmacy operator’s stock, valued at approximately $194,000.
Other large investors have also recently added to or reduced their stakes in the company. Westside Investment Management Inc. lifted its position in Walgreens Boots Alliance by 10.4% during the 2nd quarter. Westside Investment Management Inc. now owns 1,325 shares of the pharmacy operator’s stock worth $102,000 after acquiring an additional 125 shares during the period. Zions Bancorporation lifted its position in Walgreens Boots Alliance by 983.3% during the 3rd quarter. Zions Bancorporation now owns 1,365 shares of the pharmacy operator’s stock worth $105,000 after acquiring an additional 1,239 shares during the period. IHT Wealth Management LLC lifted its position in Walgreens Boots Alliance by 46.3% during the 2nd quarter. IHT Wealth Management LLC now owns 6,946 shares of the pharmacy operator’s stock worth $135,000 after acquiring an additional 2,199 shares during the period. Bristlecone Advisors LLC acquired a new stake in Walgreens Boots Alliance during the 3rd quarter worth approximately $135,000. Finally, Trustcore Financial Services LLC acquired a new stake in Walgreens Boots Alliance during the 4th quarter worth approximately $155,000. Hedge funds and other institutional investors own 61.00% of the company’s stock.
Several analysts have recently commented on the company. Barclays assumed coverage on Walgreens Boots Alliance in a report on Thursday, March 8th. They issued an “equal weight” rating and a $76.00 price target for the company. Zacks Investment Research cut Walgreens Boots Alliance from a “buy” rating to a “hold” rating in a report on Tuesday, March 6th. BidaskClub cut Walgreens Boots Alliance from a “hold” rating to a “sell” rating in a report on Wednesday, February 28th. Bank of America assumed coverage on Walgreens Boots Alliance in a report on Tuesday, February 27th. They issued a “neutral” rating and a $76.00 price target for the company. Finally, Royal Bank of Canada set a $94.00 price target on Walgreens Boots Alliance and gave the company a “buy” rating in a report on Friday, February 16th. One analyst has rated the stock with a sell rating, eleven have assigned a hold rating, eleven have issued a buy rating and one has issued a strong buy rating to the stock. Walgreens Boots Alliance presently has an average rating of “Buy” and a consensus target price of $84.75.
In other news, insider Stefano Pessina acquired 98,858 shares of Walgreens Boots Alliance stock in a transaction that occurred on Monday, January 15th. The stock was purchased at an average cost of $76.07 per share, with a total value of $7,520,128.06. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Insiders own 14.80% of the company’s stock.
Walgreens Boots Alliance Inc (NASDAQ WBA) opened at $67.57 on Friday. The stock has a market capitalization of $67,130.00, a price-to-earnings ratio of 18.67, a P/E/G ratio of 1.13 and a beta of 1.21. Walgreens Boots Alliance Inc has a 1-year low of $63.82 and a 1-year high of $87.79. The company has a current ratio of 0.96, a quick ratio of 0.47 and a debt-to-equity ratio of 0.48.
Walgreens Boots Alliance (NASDAQ:WBA) last issued its quarterly earnings data on Thursday, January 4th. The pharmacy operator reported $1.28 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.27 by $0.01. The firm had revenue of $30.74 billion during the quarter, compared to analysts’ expectations of $30.39 billion. Walgreens Boots Alliance had a return on equity of 19.15% and a net margin of 3.19%. Walgreens Boots Alliance’s revenue was up 7.9% on a year-over-year basis. During the same period in the previous year, the firm posted $1.10 earnings per share. analysts predict that Walgreens Boots Alliance Inc will post 5.79 EPS for the current year.
The company also recently disclosed a quarterly dividend, which was paid on Monday, March 12th. Investors of record on Thursday, February 15th were issued a dividend of $0.40 per share. The ex-dividend date was Wednesday, February 14th. This represents a $1.60 annualized dividend and a yield of 2.37%. Walgreens Boots Alliance’s dividend payout ratio is presently 44.20%.
COPYRIGHT VIOLATION NOTICE: This story was first posted by The Ledger Gazette and is the property of of The Ledger Gazette. If you are accessing this story on another site, it was illegally stolen and reposted in violation of U.S. & international copyright & trademark law. The legal version of this story can be viewed at https://ledgergazette.com/2018/03/17/captrust-financial-advisors-purchases-new-position-in-walgreens-boots-alliance-inc-wba.html.
Walgreens Boots Alliance Company Profile
Walgreens Boots Alliance, Inc (Walgreens Boots Alliance) is a holding company. The Company is a global pharmacy-led, health and wellbeing enterprise. Walgreens Boots Alliance operates through three divisions, including Retail Pharmacy USA, Retail Pharmacy International and Pharmaceutical Wholesale. The Company’s products are marketed under a number of brands, which include No7, the Botanics range, Almus (generic medicines), Boots Pharmaceuticals and Soap & Glory (bathing and beauty brand).
Want to see what other hedge funds are holding WBA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Walgreens Boots Alliance Inc (NASDAQ:WBA).
Receive News & Ratings for Walgreens Boots Alliance Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Walgreens Boots Alliance and related companies with MarketBeat.com's FREE daily email newsletter.